TY - JOUR
T1 - Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite
T2 - Implications for the treatment of multiple sclerosis
AU - Hooper, D. Craig
AU - Bagasra, Omar
AU - Marini, Joseph C.
AU - Zborek, Anna
AU - Ohnishi, S. Tsuyoshi
AU - Kean, Rhonda
AU - Champion, Jean M.
AU - Sarker, Ashit B.
AU - Bobroski, Lisa
AU - Farber, John L.
AU - Akaike, Takaaki
AU - Maeda, Hiroshi
AU - Koprowski, Hilary
PY - 1997/3/18
Y1 - 1997/3/18
N2 - In this study we provide further evidence associating activated cells of the monocyte lineage with the lesions of multiple sclerosis (MS). Using a combination of immunohistochemistry and reverse transcriptase-dependent in situ polymerase chain reaction analysis, we have identified monocytes expressing inducible nitric oxide synthase (iNOS) to be prevalent in the plaque areas of post mortem brain tissue from patients with MS. In addition, we have obtained evidence of the nitration of tyrosine residues in brain areas local to accumulations of iNOS-positive cells. In parallel studies we have assessed the effects of inhibitors of iNOS induction, as well as scavengers of nitric oxide and peroxynitrite in the experimental allergic encephalomyelitis model. Significant therapeutic effects were seen with the inhibitor of iNOS induction, tricyclodecan-9-xyl-xanthogenate, a nitric oxide scavenger, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, and a peroxynitrite scavenger, uric acid. In particular, treatment with high doses of uric acid virtually prevented clinical symptoms of the disease. Together with our demonstration of the presence of activated macrophages expressing high levels of iNOS and evidence of peroxynitrite formation in brain tissue from patients with MS, these findings are of importance in the development of approaches to treat this disease.
AB - In this study we provide further evidence associating activated cells of the monocyte lineage with the lesions of multiple sclerosis (MS). Using a combination of immunohistochemistry and reverse transcriptase-dependent in situ polymerase chain reaction analysis, we have identified monocytes expressing inducible nitric oxide synthase (iNOS) to be prevalent in the plaque areas of post mortem brain tissue from patients with MS. In addition, we have obtained evidence of the nitration of tyrosine residues in brain areas local to accumulations of iNOS-positive cells. In parallel studies we have assessed the effects of inhibitors of iNOS induction, as well as scavengers of nitric oxide and peroxynitrite in the experimental allergic encephalomyelitis model. Significant therapeutic effects were seen with the inhibitor of iNOS induction, tricyclodecan-9-xyl-xanthogenate, a nitric oxide scavenger, 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide, and a peroxynitrite scavenger, uric acid. In particular, treatment with high doses of uric acid virtually prevented clinical symptoms of the disease. Together with our demonstration of the presence of activated macrophages expressing high levels of iNOS and evidence of peroxynitrite formation in brain tissue from patients with MS, these findings are of importance in the development of approaches to treat this disease.
UR - http://www.scopus.com/inward/record.url?scp=12644261423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=12644261423&partnerID=8YFLogxK
U2 - 10.1073/pnas.94.6.2528
DO - 10.1073/pnas.94.6.2528
M3 - Article
C2 - 9122229
AN - SCOPUS:12644261423
VL - 94
SP - 2528
EP - 2533
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
SN - 0027-8424
IS - 6
ER -